-
ESMO: Neoadjuvant Pembro Tops Adjuvant in Stage III Melanoma
23 Dec 2025 16:36 GMT
… discussions about the new treatment options for patients at … first one is a trial that evaluated pembrolizumab in … stage IV melanoma and mucosal melanoma and acral melanoma that were … conclusions.
Finally, for mucosal melanoma, five patients were included …
-
USF researchers develop tumor-targeting cancer treatment already saving pets: Human trials could be next
23 Dec 2025 05:58 GMT
… allows therapeutic molecules, including drug therapy paired with immunotherapy, … treat animals with promising results. Strange says the treatment … funding a year-long melanoma trial in dogs. Researchers … If the team receives FDA clearance, human testing could …
-
A Cell Membrane-Coated Gold Nanoparticle-Based Drug Delivery System for Enhanced Antitumor Therapy in Breast Cancer
22 Dec 2025 11:27 GMT
… drugs have previously received approval from the US Food and Drug Administration (FDA … the 4T1 mouse melanoma model followed the … human dose escalation clinical trial. Clin Cancer Res … drug delivery strategies for breast cancer treatment. Biomed Pharmacother. …
-
Medicus Pharma completes SkinJect trial enrolment – ICYMI
20 Dec 2025 15:34 GMT
… in its SkinJect clinical trial.
The company has now … a novel, noninvasive treatment for non-melanoma skin diseases, specifically basal … . Thank you. At Medicus Pharma, since the fall of 2023 … in essence, putting the medication directly into the cancer, right …
-
<![CDATA[Adjuvant Nivolumab/Relatlimab Shows No Added Benefit in Resected Melanoma]]>
20 Dec 2025 01:32 GMT
… of nivolumab monotherapy (n = 546). Treatments were administered intravenously for every … /IV melanoma: the randomized phase 3 RELATIVITY-098 trial. Nature Med. 2025 …
3. U.S. Food and Drug Administration approves first LAG-3 …
-
<![CDATA[Neoadjuvant and Adjuvant Treatment Approaches Expand Options in CSCC and Melanoma]]>
19 Dec 2025 22:12 GMT
… treatment of patients with resectable melanoma, beginning with the phase 3 NADINA trial … ;www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-cemiplimab … in resectable stage III melanoma. N Engl J Med. 2024;391(18 …
-
A New Therapy for Melanoma
19 Dec 2025 18:29 GMT
… are the typical treatments. But now, the FDA has approved a … patients battling late-stage melanoma, offering hope when options … immune cells to aggressively attack melanoma.
“What we' … for patients with advanced-stage melanoma.
Ongoing clinical trials are …
-
Aussie researchers find genetic ‘safety switch’ in cancer cells, opening the way to better immunotherapy drugs
19 Dec 2025 16:18 GMT
… of current immunotherapy drugs for cancers, including melanoma.
The so- … future of how we treat cancer treatment”.
“The research came … with immunotherapy.
Australia’s melanoma rates have increased from … to Cancer Council data. Melanoma caused an estimated 1340 …
-
CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin Phototypes
19 Dec 2025 08:28 GMT
… are disparities in access to melanoma treatments; black patients have a … CAEs,2 and treatment guidelines to treat common CAEs induced … patients, including physicians, nurses, pharmacists, and advanced providers. A … skin of color. J Drugs Dermatol. 2024;23:100 …
-
Peptide Cancer Vaccine Market Poised for Rapid Growth, Set to Hit USD 4.93 Billion by 2034
24 Dec 2025 08:05 GMT
… trial) is crucial to developing more effective cancer treatment … with hard-to-treat solid tumors. The … Lung Cancer
• Melanoma
• Prostate Cancer
• Others
Melanoma is one of … oncology, biotechnology, and pharmaceutical development are increasingly viewing …